Beam Therapeutics Inc
BEAM
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.83B
Close$
$-25.93
197.3% downside
Current Fair Value
197.3% downsideOvervalued by 197.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.83 Billion |
|---|---|
| Enterprise Value | $2.69 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.81 |
| Beta | 2.18 |
| Outstanding Shares | 103,262,000 |
Return
| Return on Equity | -5.59% |
|---|---|
| Return on Assets | -4.39% |
| Return on Invested Capital | -5.79% |
Valuation & Multiples
| P/E Ratio | -43.02 |
|---|---|
| PEG | 314.36 |
| Price to Sales | 26.64 |
| Price to Book Ratio | 2.42 |
| Enterprise Value to Revenue | 20.37 |
| Enterprise Value to EBIT | -33.12 |
| Enterprise Value to Net Income | -42 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
$-1.02
Average shareholder expectationRevenue Estimate
$11.11 M
Average shareholder expectationNext Earnings Call
Expected Date
August 4, 2026
EPS Estimate
$-1.11
Average shareholder expectationRevenue Estimate
$16.37 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 52.45% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.10%▼ 109.35% |
|---|---|
| Total Invested | $3.38M▼ 99.87% |
| Investors Holding | 21▼ 242.00% |
ESG Score
No data